All news

Biosimilar medicines – Recent regulatory developments in the European Union and France

What is a biosimilar product? A biosimilar is a biological medicine (i.e., a medicine whose active substance is made by

Legal 500 EMEA 2023 rankings

DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2023 categories : In addition to these collective

PRESS RELEASE – DELSOL Avocats advised AgorIA Santé in setting up the consortium and obtaining CNIL authorisation to create a health data warehouse

Launched in June 2021 by three founding members (AstraZeneca, Docaposte and Impact Healthcare), the AgorIA Santé consortium aims at bringing

Legal 500 EMEA 2022 rankings

DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2022 categories: In addition to these collective rankings,

PRESS RELEASE – DELSOL Avocats is strengthening its Life Sciences practice with the addition of Gaëlle Merlier as a partner

Gaëlle Merlier is joining the DELSOL Avocats Life Sciences practice as a partner accompanied by associate Bastien Pavec, who worked

PRESS RELEASE – DELSOL Avocats assisted AstraZeneca, Docaposte and Impact Healthcare in the setting-up of the “Agoria Santé” consortium

AstraZeneca, Docaposte and Impact Healthcare have created the «Agoria Santé» consortium to provide public and private players with a controlled

Legal 500 EMEA 2021 rankings

DELSOL Avocats is proud to be ranked in 6 Legal 500 EMEA 2021 categories : The Regions – Tier 1

Legal 500 Paris 2020 rankings

DELSOL Avocats is proud to be ranked in 8 categories by the Legal 500 Paris 2020 : -*Construction – Tier

More committed than ever

Considering the latest developments relating to Covid-19 and government announcements, we would like to inform you with full transparency of